Literature DB >> 7810536

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha.

H Yamabe1, R J Johnson, D R Gretch, H Osawa, H Inuma, T Sasaki, M Kaizuka, N Tamura, S Tsunoda, Y Fujita.   

Abstract

A 42-year-old man with hepatitis C virus infection, cryoglobulinemia, hypocomplementemia, and nephrotic syndrome is reported. The kidney biopsy showed membranoproliferative glomerulonephritis. The patient was treated with interferon-alpha for 2 months. After the treatment, serum hepatitis C virus RNA became negative and nephrotic syndrome remitted. Repeat biopsy of the kidney revealed an improvement in renal histology. This case confirms an association between hepatitis C virus infection and membranoproliferative glomerulonephritis and the usefulness of interferon-alpha for treatment.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7810536     DOI： 10.1016/0272-6386(95)90628-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


  6 in total

1.  Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.

Authors:  Marilyn Zeman; Patricia Campbell; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

2.  Renal failure associated with hepatitis C virus infection. Improvement in renal function after treatment with interferon-alpha.

Authors:  P L Moses; E L Krawitt; W Aziz; H L Corwin
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.

Authors:  Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Masahiro Kobayashi; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Miharu Hirakawa; Satoshi Saito; Kenji Ikeda; Hiromitsu Kumada
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

4.  Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus.

Authors:  Toru Sanai; Izumi Watanabe; Tadashi Hirano; Masaru Nakayama; Hironori Sakai; Noriko Uesugi; Kohsuke Masutani; Ritsuko Katafuchi; Hideki Hirakata; Mitsuo Iida
Journal:  Int Urol Nephrol       Date:  2008-02-12       Impact factor: 2.370

Review 5.  Morphologic features of extrahepatic manifestations of hepatitis C virus infection.

Authors:  Huaibin M Ko; Juan C Hernandez-Prera; Hongfa Zhu; Steven H Dikman; Harleen K Sidhu; Stephen C Ward; Swan N Thung
Journal:  Clin Dev Immunol       Date:  2012-08-05

Review 6.  Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.

Authors:  Michiko Shimada; Norio Nakamura; Tetsu Endo; Hideaki Yamabe; Masayuki Nakamura; Reiichi Murakami; Ikuyo Narita; Hirofumi Tomita
Journal:  BMC Nephrol       Date:  2017-03-29       Impact factor: 2.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.